Deferred Tax Assets, Valuation Allowance of Kronos Bio, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Kronos Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Kronos Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $141,440,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Kronos Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $141,440,000 +$18,474,000 +15% 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q4 2023 $122,966,000 +$22,310,000 +22% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q4 2022 $100,656,000 +$41,943,000 +71% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $58,713,000 +$37,916,000 +182% 31 Dec 2021 10-K 21 Mar 2024 2023 FY
Q4 2020 $20,797,000 +$15,061,000 +263% 31 Dec 2020 10-K 15 Mar 2023 2022 FY
Q4 2019 $5,736,000 31 Dec 2019 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.